Harrow Inc (HROW)

NASDAQ

$44.45

Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.

Sector:

Industry:

68 analysts

Buy

Target: $67.75 (+52.42%)

Market Cap

$1.60B

Revenue 5Y CAGR

+38.62%

FCF 5Y CAGR

+51.26%

Free Cash Flow Yield

0.89%

Adjust inflation

Log

Valuation

Market Cap$1.60B

Forward P/E312.50

P/S5.96

P/B53.68

Profitability

Total Revenue (TTM)$269M

Gross Profit (TTM)$199M

EBITDA$22M

Profit Margin-62.4%

Operating Margin-49.9%

EPS-$0.40

Financial Health

Debt-to-Equity1045.1%

Free Cash Flow Yield0.89%

Growth & Risk

Revenue 5Y CAGR+38.62%

FCF 5Y CAGR+51.26%

Beta (5Y)1.72

Sharpe Ratio0.60